Blueprint Medicines shares owned by Emerald Advisers
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Emerald Advisers
from 13F filings
Historical chart of Emerald Advisers investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Emerald Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $43M | 466k | 92.24 |
| 2023-09-30 | $31M | 607k | 50.22 |
| 2023-06-30 | $31M | 496k | 63.20 |
| 2023-03-31 | $20M | 438k | 44.99 |
| 2022-12-31 | $17M | 391k | 43.81 |
| 2022-09-30 | $21M | 319k | 65.89 |
| 2021-12-31 | $18M | 170k | 107.11 |
| 2021-09-30 | $24M | 234k | 102.81 |
| 2021-06-30 | $20M | 226k | 87.96 |
| 2021-03-31 | $25M | 260k | 97.23 |
| 2020-12-31 | $33M | 298k | 112.15 |
| 2020-09-30 | $35M | 381k | 92.70 |
| 2020-06-30 | $31M | 396k | 78.00 |
| 2020-03-31 | $24M | 416k | 58.48 |